S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 170 participants.
Also called NCT03226340
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 170 participants
- Registry
-
NCT03226340
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03226340. Randomized; no masking; primary purpose treatment. Start 2015-12-02 (actual); primary completion 2018-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- S-amlodipine 2.5mg + Chlorthalidone 25mg
- Intervention (Drug)
- S-amlodipine 2.5mg + Telmisartan 40mg
- Lead sponsor
- Seoul National University Bundang Hospital
- Collaborator
- Hanlim Pharm. Co., Ltd.
Record details
- Record id
cardio:ct-nct03226340- Content hash
ba52eaf3c1f3eeb3cb1cb492642cce503856ae7d658dad32351dbfa5f9ff9887